SEC Form 4/A · accession 0001654954-18-010580
Monopar Therapeutics · MNPR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Kim R Tsuchimoto
Officer — Chief Financial Officer
Period of report
Aug 28, 2018
Accepted (ET)
Sep 27, 2018 · 7:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645469
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionsF1 | $6.00 | Aug 28, 2018 | A | 41,100 | A | Apr 1, 2019 | Aug 27, 2028 | Common Stock | 41,100 | 41,100 | D |
Explanation of responses
- F1Stock options vest 6/51 on the six-month anniversary of vesting commencement date of October 1, 2018 and 1/51 per month thereafter.